The application dimension of the farsightedness correction market is dominated by prescription glasses, which account for roughly 45% of total revenue according to the latest market taxonomy. Their share reflects the low entry cost, broad consumer acceptance, and continuous demand for updated frames. Contact lenses represent the second‑largest application segment at about 25%; growth is driven by advances in material science that improve oxygen permeability and comfort, expanding the user base beyond traditional spectacles. Refractive surgery, encompassing LASIK, PRK and SMILE, contributes approximately 20% of market size, with its proportion rising as surgical outcomes improve and procedural costs decline. Implantable lenses, primarily phakic intra‑ocular lenses, hold a 7% share, reflecting their niche status among patients unsuitable for corneal reshaping. Orthokeratology, a reversible corneal reshaping technique, remains a marginal but growing segment at 3%, supported by increasing interest in non‑surgical, overnight correction options. Collectively, these application categories define the overall market structure and guide strategic investment decisions.
